- Case report
- Open Access
- Open Peer Review
Benign Ancient Schwannoma of the abdominal wall: An unwanted birthday present
© Bhatia et al; licensee BioMed Central Ltd. 2010
- Received: 13 July 2009
- Accepted: 6 January 2010
- Published: 6 January 2010
There has been a recent growth in the use of whole body Computerised Tomography (CT) scans in the private sector as a screening test for asymptomatic disease. This is despite scant evidence to show any positive effect on morbidity or mortality. There has been concern raised over the possible harms of the test in terms of radiation exposure as well as the risk and anxiety of further investigation and treatment for the large numbers of benign lesions identified.
A healthy 64 year old lady received a privately funded whole body CT scan for her birthday which revealed an incidental mass in the right iliac fossa. This was investigated with further imaging and colonoscopy and as confident diagnosis could not be made, eventually excised. Histology demonstrated this to be a benign ancient schwannoma and we believe this to be the first reported case of an abdominal wall schwannoma in the English literature
Ancient schwannomas are rare tumours of the peripheral nerve sheaths more usually found in the head, neck and flexor surfaces of extremities. They are a subtype of classical schwannomas with a predominance of degenerative changes. Our case highlights the pitfalls of such screening tests in demonstrating benign disease and subjecting patients to what turns out to be unnecessary invasive investigation and treatment. It provides evidence as to the consequences of the large number of false positive results that are created by blind CT scanning of asymptomatic patients i.e. its tendency to detect pseudodiesease rather than affect survival rates. Should the number of scans increase there may be an unnecessary burden on NHS resources due to the large numbers of benign lesions picked up, that are then referred for further investigation.
- Computerise Tomography
- Malignant Peripheral Nerve Sheath Tumour
- Computerise Tomography Scan
- Unnecessary Burden
- Right Iliac Fossa
In recent years private entrepreneurs have recognised, some might say exploited, a market for radiological screening tests [1, 2]. One of these tests, Computerised Tomography (CT), in particular whole body CT, is tendered as a possible tool to identify asymptomatic thoracic and abdominal disease. However, before any procedure is adopted to screen for disease, its cost, benefit and risk should all be taken into account and before this happens the value of the test must remain unproven and unknown To date, this evaluation has not been carried out with whole body CT screening in asymptomatic individuals . This may be due to the huge cost and long follow up period required for such a trial as well as the fact that grants are unlikely to be given to research what is increasingly seen as an entrepreneurial scheme . Hence, a number of clinical, ethical and health-economical issues have been raised by medical professionals in response to the growth of such an unproven test in the private sector. Although these centre on the lack of evidence that blind CT scanning of asymptomatic individuals produces any benefit in terms of identifying or precluding disease, they also emphasise the potential harm from radiation as well as from further, often invasive, investigations which are offered in the large number of false positive cases frequently seen. Furthermore, some have voiced concern at the growing public expenditure spent on investigating the large number incidental lesions uncovered on private CT scans. In this paper, we present our treatment for a lesion identified on a private whole body CT scan, given to our patient as a birthday present, as well as recount what we believe to be the first reported case in the English literature of an abdominal wall ancient schwannoma. We discuss the clinical, histological and radiological features of ancient schwannomas, as well as discuss in further depth, the controversy surrounding whole body CT screening in asymptomatic individuals.
A healthy 64 year old lady received a LifeScan (privately funded whole body CT scan) for her birthday which revealed an incidental mass in the right iliac fossa (RIF). This was investigated further with a colonoscopy which revealed small benign polyps only. Initially a putative diagnosis of GastroIntestinal Stromal Tumour (GIST) was considered and the patient referred to our NHS Colorectal outpatient clinic.
Ancient schwannomas are rare tumours originating from Schwann cells in the peripheral nerve sheath . Up to 20% of cases are associated with Neurofibromatosis Type 1 . They usually arise in females  between the ages of 20-50 years,  with a predilection for the head, neck and flexor surfaces of extremities [8, 9]. However, there have been sporadic cases of these tumours arising in the retroperitoneum, pelvis, perineum, adrenals, kidneys and even masquerading as an inguinal hernia [9–14]. They may be asymptomatic and only found incidentally on examination or imaging. However, occasionally they produce pressure effects on surrounding large nerves .
Ancient schwannomas are a subtype of classic schwannomas with a predominance of degenerative changes including cyst formation, calcification, haemosiderin deposition, interstitial fibrosis, and vascular hyaline degeneration . They show spindle cells with focal nuclear palisading patterns  arranged in distinctive dense (Antoni A) and loose (Antoni B) areas [6, 16]. Usually, connective tissue fragments (Verocay bodies) and intranuclear vacuoles (lochkern) are present [17–19]. These features may sometimes be seen on CT, which may demonstrate a well circumscribed, heterogeneous mass of low density which fits with the microscopic pattern of cellular and hypocellular areas. The term "ancient" was used as a description for the degenerative changes apparent on microscopy [20, 21] which was thought to be due to the increasing tumour size causing vascular insufficiency .
There have been less than ten reports in the literature of malignant lesions arising from schwannomas [23–25] although some argue that these malignant tumours may arise de novo  rather than having undergone secondary anaplastic change [19, 26] and that recurrence after resection may actually be due to incomplete excision .
Schwannomas react strongly with S100 protein and immunohistochemistry can be used to aid diagnosis and to differentiate them from malignant peripheral nerve sheath tumours [24, 28, 29]. This is especially helpful as the occasional appearance of hyperchromatic cells and cytological atypia may lead to diagnostic difficulty [19, 22] especially when fine needle aspiration cytology (FNAc) is used to make a diagnosis [5, 7, 18, 21, 22, 28, 30, 31] as this technique rarely produces an adequate enough sample . False positive diagnosis of malignancy may lead to over treatment with radical resections being carried out unnecessarily. Together with the clinical history, the characteristic radiological findings may help distinguish schwannomas and prevent unnecessary resection for such a benign condition [32–34]. However, as in our case, this is rarely possible and surgical resection is still common [6, 27, 35, 36].
Our case highlights one of the main pitfalls of whole body CT scan used as a screening method for disease. This lady suffered considerable mental anguish, endured extremely invasive procedures and the significant risks that accompany them, for a condition that may never have caused any symptoms. Studies have shown that up to 86% patients who undergo these scans show at least one abnormal finding and up to 37% of individuals receive recommendations for further investigation . Whether these findings translate into clinical significance is doubtful. Given the large number of findings identified by such a crude test, there have been calls for guidelines to be drawn up to as to help clinicians decide which abnormalities warrant further investigation [38, 39]. Although such guidelines may be helpful, this may be harder for lesions detected on abdominal or pelvic CT given that the often non contrast CT method used for screening, rarely provides enough detailed information on which to guide management. Additionally, different guidelines would have to be drawn up for different organs. Yet this would have been of little benefit in our case as the lesion was adherent to the anterior abdominal wall. In spite of this, the few supporters of screening CT do point out that as with mammograms, false positive results may decrease with increased use and experience of the test .
As well as the high false positive rate, the other main criticism levelled is that there is scant evidence that whole body CT reduces morbidity or mortality  even if it were to correctly identify true positives or negatives. For example, lead time bias may mean earlier diagnosis of disease but not improved survival. Length bias may mean overrepresented diagnoses of slower progressing disease (more likely to be picked up by a static screening test such as a CT scan) but again not actually improved survival times. Overdiagnosis bias (demonstrated effectively in our case) occurs when pseudodiesease- i.e. cases that probably wouldn't have caused disease were they not picked up, is not adjusted for . True negative results would of course reassure individuals, however this may lead them carrying on with unhealthy lifestyle habits in the knowledge that they have been given the "all clear". Of course, false negatives are probably the worst outcomes for both the patient and reporting radiologist .
Given the lack of evidence of any tangible benefit of CT screening tests, some have speculated they may actually do more harm than good. There is an ongoing debate as to whether the risks of radiation from whole body CT may be harmful to asymptomatic individuals and differences stem from the calculation of radiation dose depending on type of scanner and protocol used or whether interval CT scans are offered [42, 43]. Although it is hard to prove these associations, given that we are cautious with regards to radiation exposure in our usual practice it seems prudent to apply the same hesitancy when it comes to unproven screening tests.
But what for the argument that CT screening tests offer individuals control over their own healthcare for those that can afford it? Although patients who present for these tests may value the consumer empowerment over their healthcare management and desire "comprehensive wellness" (i.e. assurance that they are free of disease even in the absence of symptoms),  one has to remember that CT screening may have a large false positive rate and as in our report, the costs of the additional investigations will mostly be borne by the NHS, despite the initial screening test being performed in the private sector. There is concern that should CT screening become more widespread, the financial burden of distinguishing the incidentalomas from true disease be may end up being shared by the taxpayer and thereby increase national health expenditure [1, 44] hence widening the disparity of healthcare options for the less well-off . Of course this is an argument that may be made of other unproven treatments performed only in the private sector. However the targeted marketing of CT screening to the asymptomatic, economically comfortable and educated health conscious consumer  as well as the prima fasciae logic embedded such a test should the benefits and risks not be adequately explained, brings the potential for a huge number of "worried well" presenting to publicly funded surgical outpatients clinics.
In this study we have presented the first reported case in the English literature of an abdominal wall ancient schwannoma and discussed the key clinical, radiological and pathological features of the condition. As this was picked up asymptomatically on a private health whole body CT screen given to the patient as a birthday present, we have extolled the pitfalls of such tests as well as offered an insight into the clinical, ethical and health economic issues that they raise. Wider marketing and availability of these services may lead to increased non evidence based patient-led screening in the private sector. Unfortunately, this may add an unnecessary burden to public health resources.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
RKB is a house officer in General Surgery. BEL is a Consultant Surgeon. AB and MR are Specialist Registrars in General Surgery and Pathology respectively.
The authors would like to thank the patient for allowing us to share her case in a medical journal. Written consent was obtained from the patient for publication of study
- Fenton JJ, Deyo RA: Patient Self-Referral for Radiological Screening Tests: Clinical and Ethical Concerns. Journal of the American Board of Family Practitioners. 2003, 16 (6): 494-501. 10.3122/jabfm.16.6.494.View ArticleGoogle Scholar
- Dixon AK: Whole body CT Screening. British Journal of Radiology. 2004, 370-371. 10.1259/bjr/14928972. 77Google Scholar
- Rogers LF: Whole Body CT Screening: Edging towards commerce. American Journal of Roentgenology. 2002, 179: 823-824.View ArticlePubMedGoogle Scholar
- Anderiesz C, Elwood JM, McAvoy BR, Kenny LM: Whole body CT Screening: looking for trouble?. Medical Journal of Australia. 2004, 181 (6): 295-296.PubMedGoogle Scholar
- Hajdu S: Peripheral nerve sheath tumors histiogenesis, classification, and prognosis. Cancer. 72 (1): 3549-3552. 10.1002/1097-0142(19931215)72:12<3549::AID-CNCR2820721202>3.0.CO;2-Y.Google Scholar
- Theodosopoulos T, Stafyla VK, Tsiantoula PK: Special problems encountering surgical management of large retroperitoneal schwannomas. World Journal of Surgical Oncology. 2008, 107-10.1186/1477-7819-6-107. 6Google Scholar
- White W, Shiu MH, Rosenblum MK, Erlandson RA, Woodruff JM: Cellular schwannoma: A clinicopathological study of 57 patients and 58 tumors. Cancer. 1990, 66 (6): 1266-75. 10.1002/1097-0142(19900915)66:6<1266::AID-CNCR2820660628>3.0.CO;2-E.View ArticlePubMedGoogle Scholar
- Ishihara T, Ono T: Degenerated neurilemoma (ancient schwannoma). Journal of Dermatology. 2001, 28 (4): 221-225.View ArticlePubMedGoogle Scholar
- El-Barhawy M, Khoubehi B, Hrouda D: Perirenal schwannoma: a case report. Journal of Medical Case Reports. 2008, 2: 189-194. 10.1186/1752-1947-2-189.View ArticleGoogle Scholar
- Ninos A, Douridas G, Liapi G: Schwannoma in the inguinal canal masquerading an inguinal hernia. Hernia. 2004, 8 (1): 73-5. 10.1007/s10029-003-0146-9.View ArticlePubMedGoogle Scholar
- Tsimoyiannis E, Zagaliki A, Demou A: Pelvic retroperitoneal schwannoma presenting as a gynaecological mass: Case report. European Journal of Gynaecological Oncology. 2005, 26 (1): 117-119.PubMedGoogle Scholar
- Santiago C, Lucha P: Atypical presentation of a rectorectal ancient schwannoma: A case report and review of the literature. Military medicine. 2008, 173 (8): 814-6.View ArticlePubMedGoogle Scholar
- Pante S, Terranova ML, Leonello G: Perineal Schwannoma. Canadian Journal of Surgery. 2009, 52 (1): E8-E9.PubMed CentralGoogle Scholar
- Choudry HA, Nikfarjam M, Liang JJ: Diagnosis and management of retroperitoneal ancient schwannomas. World Journal of Surgical Oncology. 2009, 7: 12-10.1186/1477-7819-7-12.View ArticlePubMedPubMed CentralGoogle Scholar
- Hide I: Giant ancient schwannoma of the pelvis. Skeletal Radiology. 2000, 29 (9): 538-542. 10.1007/s002560000266.View ArticlePubMedGoogle Scholar
- Giglio M, Giasotto V, Medica1 M: Retroperitoneal ancient schwannoma: case report and analysis of clinico-radiological findings. Annuls of Urology. 2002, 36: 104-6.View ArticleGoogle Scholar
- Dahl I: Ancient neurilemoma (schwannoma). Acta Pathologica et Microbiologica Scandinavica Section Pathology. 1977, 85 (6): 812-8.Google Scholar
- Klijanienko J, Caillaud JM, Lagace R: Cytohistologic Correlations in Schwannomas (Neurilemoma) including "Ancient," Cellular, and Epitheloid Variants. Diagnostic Cytopathology. 34 (8): 517-522. 10.1002/dc.20320.Google Scholar
- Woodruff JM: The Pathology and Treatment of Peripheral Nerve Tumors and Tumor Like Conditions. Cancer Journal for Clinicians. 1993, 43: 290-308. 10.3322/canjclin.43.5.290.View ArticleGoogle Scholar
- Ackerman LV, Taylor FH: Neurogenous tumours within the thorax: a clinicopathological evaluation of forty-eight cases. Cancer. 1951, 4 (4): 669-91. 10.1002/1097-0142(195107)4:4<669::AID-CNCR2820040405>3.0.CO;2-B.View ArticlePubMedGoogle Scholar
- Dodd LG, Marom EM, Dash RC: Fine-Needle Aspiration Cytology of "Ancient" Schwannoma. Diagnostic Cytopathology. 20 (5): 307-311. 10.1002/(SICI)1097-0339(199905)20:5<307::AID-DC12>3.0.CO;2-F.Google Scholar
- Argeny ZB, Balogh K, Abraham AA: Degenerative ("ancient") changes in benign cutaneous schwannoma: A light microscopic, histochemical and immunohistochemical study. Journal of Cutaneous Pathology. 1993, 20: 148-153. 10.1111/j.1600-0560.1993.tb00232.x.View ArticleGoogle Scholar
- Rasbridge SA, Browse NL, Tighe JR: Malignant nerve sheath tumour arising in a benign ancient schwannoma. Histopathology. 14 (5): 525-528. 10.1111/j.1365-2559.1989.tb02189.x.Google Scholar
- Mikami Y, Hidaka T, Akisada T: Malignant peripheral nerve sheath tumor arising in benign ancient schwannoma: A case report with an immunohistochemical study. Pathology International. 2000, 50: 156-161. 10.1046/j.1440-1827.2000.01019.x.View ArticlePubMedGoogle Scholar
- Yousem SA, Colby T, Urich H: Malignant Epithelial Schwannoma arising in a benign Schwannoma: A Case report. Cancer. 1985, 55: 2799-2803. 10.1002/1097-0142(19850615)55:12<2799::AID-CNCR2820551214>3.0.CO;2-3.View ArticlePubMedGoogle Scholar
- Trojanowski JQ, Kleinman GM, Proppe KH: Malignant Tumors of Nerve Sheath Origin. Cancer. 1980, 46: 1202-1212. 10.1002/1097-0142(19800901)46:5<1202::AID-CNCR2820460521>3.0.CO;2-5.View ArticlePubMedGoogle Scholar
- Rogatsch H, Bartsch G, Stenzi A: Treatment of giant ancient pelvic schwannoma. Techniques in Urology. 2001, 7 (4): 296-298.PubMedGoogle Scholar
- McGee RS, Ward WS, Kilpatrick SE: Malignant Peripheral Nerve Sheath Tumor: A Fine-Needle Aspiration Biopsy Study. Diagnostic Cytopathology. 17 (4): 298-305. 10.1002/(SICI)1097-0339(199710)17:4<298::AID-DC12>3.0.CO;2-J.Google Scholar
- Domanski HA, Akerman M, Engellau J: Fine-Needle Aspiration of Neurilemoma (Schwannoma). A Clinicocytopathologic Study of 116 Patients. Diagnostic Cytopathology. 34 (6): 403-412. 10.1002/dc.20449.Google Scholar
- Ryd W, Mugal S, Ayyash K: Ancient Neurilemoma: A Pitfall in the Cytologic Diagnosis of Soft-Tissue Tumors. Diagnostic Cytopathology. 1986, 2 (3): 244-247. 10.1002/dc.2840020317.View ArticlePubMedGoogle Scholar
- Jakowski JD, Wakely PE, Jimenez RE: An uncommon type of adrenal incidentaloma: a case report of a schwannoma of the adrenal medulla with cytological, histological, and ultrastructural correlation. Annals of Diagnostic Pathology. 2008, 12: 356-361. 10.1016/j.anndiagpath.2008.06.003.View ArticlePubMedGoogle Scholar
- Loke TKL, Yuen NWF, Lo KKL: Retroperitoneal ancient schwannoma: Review of the clinico-radiological features. Australian Radiology. 1998, 42 (2): 136-138. 10.1111/j.1440-1673.1998.tb00590.x.View ArticleGoogle Scholar
- Takeuchi M: Ancient schwannoma of the female pelvis. Additional Imaging. 2008, 33 (2): 247-252.Google Scholar
- Hennigan TW, Branfoot AC, Theodorou NA: Ancient neurilemoma of the pelvis. Journal of the Royal Society of Medicine. 1992, 85: 416-417.PubMedPubMed CentralGoogle Scholar
- Su CM, Li CC, Wang HJ: Hand assisted laparoscopic resection of a retroperitoneal schwannoma: A case report. Formosan Journal of Surgery. 2003, 36 (1): 25-28.Google Scholar
- Yoshino T, Yoneda K: Laparoscopic resection of a retroperitoneal ancient schwannoma: a case report and review of the literature. Anticancer Research. 2008, 28 (5B): 2889-2891.PubMedGoogle Scholar
- Furtado CD, Aguirre DA, Dang D: Whole Body CT Screening: Spectrum of Findings and Recommendations in 1192 Patients. Radiology. 2005, 237: 385-394. 10.1148/radiol.2372041741.View ArticlePubMedGoogle Scholar
- Hall F: Letters to the Editor: Callback and Follow up Guidance for Whole Body CT Screening. Radiology. 2006, 241 (2): 627-628. 10.1148/radiol.2412051871.View ArticlePubMedGoogle Scholar
- Mac Mohan H, Austin JHM, Gamsu G: Guidelines for the management of small pulmonary nodules detected on CT Scans: a statement from the Fleischner Society. Radiology. 2005, 237: 395-400. 10.1148/radiol.2372041887.View ArticleGoogle Scholar
- Hall FM: Letters: CT Screening Examinations. American Journal of Roentgenology. 2003, 1178-1179. 180Google Scholar
- Modic MT, Obuchowski N: Whole body CT screening for cancer and coronary disease: Does it pass the test?. Cleveland Clinic Journal of Medicine. 2004, 71 (1): 47-56. 10.3949/ccjm.71.1.47.View ArticlePubMedGoogle Scholar
- Brener DJ, Elliston CD: Estimated Radiation Risks Potentially Associated with Full Body Screening. Radiology. 2004, 232: 735-738. 10.1148/radiol.2323031095.View ArticleGoogle Scholar
- Twombly R: Full Body CT Screening: Preventing or Producing Cancer. Journal of the National Cancer Institute. 2004, 96 (24): 1650-1651.View ArticlePubMedGoogle Scholar
- Kolber CT, Zipp G, Glendinning D, Mitchell JJ: Patient Expectations of Full Body CT Screening. American Journal of Roentgenology. 2007, 188: W297-W304. 10.2214/AJR.06.0062.View ArticlePubMedGoogle Scholar
- Illes J, Fan E, Koenig BA: Self Referred Whole Body CT Imaging: Current Implications for Health Care Consumers. Radiology. 2003, 228: 246-351. 10.1148/radiol.2282021083.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2482/10/1/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.